Veterinary Rabies Vaccines Market Size & Share Report, 2032

Veterinary Rabies Vaccines Market - By Animal Type (Companion [Dog, Cat], Livestock [Cattle, Sheep & Goat]), Application (Pre, Post- exposure Prophylaxis), Route of Administration (Oral, Injectable), End-use, Global Forecast (2024 – 2032)

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary 

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights 

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Rising incidence of rabies

3.2.1.2&nbsp;&nbsp;&nbsp; Rising pet ownership globally

3.2.1.3&nbsp;&nbsp;&nbsp; Favorable government regulations and policies

3.2.1.4&nbsp;&nbsp;&nbsp; Increased awareness about rabies and its prevention

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp; High cost of rabies vaccines

3.2.2.2&nbsp;&nbsp;&nbsp; Lack of awareness

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Pipeline analysis

3.6&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Animal Type, 2021 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Companion animals

5.2.1&nbsp;&nbsp;&nbsp; Dogs

5.2.2&nbsp;&nbsp;&nbsp; Cats

5.2.3&nbsp;&nbsp;&nbsp; Other companion animals

5.3&nbsp;&nbsp;&nbsp; Livestock animals

5.3.1&nbsp;&nbsp;&nbsp; Cattle

5.3.2&nbsp;&nbsp;&nbsp; Sheep &amp; goats

5.3.3&nbsp;&nbsp;&nbsp; Other livestock animals

5.4&nbsp;&nbsp;&nbsp; Wildlife

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2021 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Pre exposure prophylaxis

6.3&nbsp;&nbsp;&nbsp; Post exposure prophylaxis

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Route of Administration, 2021 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Oral

7.3&nbsp;&nbsp;&nbsp; Injectable

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End-use, 2021 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Veterinary hospitals &amp; clinics

8.3&nbsp;&nbsp;&nbsp; Animal shelters &amp; rescue organizations

8.4&nbsp;&nbsp;&nbsp; Research institutes

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2032 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; North America

9.2.1&nbsp;&nbsp;&nbsp; U.S.

9.2.2&nbsp;&nbsp;&nbsp; Canada

9.3&nbsp;&nbsp;&nbsp; Europe

9.3.1&nbsp;&nbsp;&nbsp; Germany

9.3.2&nbsp;&nbsp;&nbsp; UK

9.3.3&nbsp;&nbsp;&nbsp; France

9.3.4&nbsp;&nbsp;&nbsp; Spain

9.3.5&nbsp;&nbsp;&nbsp; Italy

9.3.6&nbsp;&nbsp;&nbsp; Netherlands

9.3.7&nbsp;&nbsp;&nbsp; Rest of Europe

9.4&nbsp;&nbsp;&nbsp; Asia Pacific

9.4.1&nbsp;&nbsp;&nbsp; Japan

9.4.2&nbsp;&nbsp;&nbsp; China

9.4.3&nbsp;&nbsp;&nbsp; India

9.4.4&nbsp;&nbsp;&nbsp; Australia

9.4.5&nbsp;&nbsp;&nbsp; South Korea

9.4.6&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

9.5&nbsp;&nbsp;&nbsp; Latin America

9.5.1&nbsp;&nbsp;&nbsp; Brazil

9.5.2&nbsp;&nbsp;&nbsp; Mexico

9.5.3&nbsp;&nbsp;&nbsp; Rest of Latin America

9.6&nbsp;&nbsp;&nbsp; Middle East and Africa

9.6.1&nbsp;&nbsp;&nbsp; Saudi Arabia

9.6.2&nbsp;&nbsp;&nbsp; South Africa

9.6.3&nbsp;&nbsp;&nbsp; UAE

9.6.4&nbsp;&nbsp;&nbsp; Rest of Middle East and Africa

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles

10.1&nbsp;&nbsp;&nbsp; Biog&eacute;nesis Bago S.A.

10.2&nbsp;&nbsp;&nbsp; Bioveta, a.s.

10.3&nbsp;&nbsp;&nbsp; Boehringer Ingelheim International GmbH

10.4&nbsp;&nbsp;&nbsp; Ceva Sant&eacute; Animale S.A.

10.5&nbsp;&nbsp;&nbsp; Dyntec

10.6&nbsp;&nbsp;&nbsp; Elanco Animal Health Incorporated

10.7&nbsp;&nbsp;&nbsp; Indian Immunologicals Limited

10.8&nbsp;&nbsp;&nbsp; Merck &amp; Co., Inc.

10.9&nbsp;&nbsp;&nbsp; Vaxxinova International B.V.

10.10&nbsp;&nbsp;&nbsp; Virbac S.A.

10.11&nbsp;&nbsp;&nbsp; Zoetis Inc.

&nbsp;&nbsp;

Veterinary Rabies Vaccines Market

Get a free sample of this report